Kaplan-Meier survival plots indicated that glioma patients with high NLRC4 expression had a significantly lower overall survival than those with low NLRC4 expression, whereas the expression of NLRP3 did not have a significant association with overall survival. This evidence concerns the gene NLRC4 and central nervous system cancer.